Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2130171 | 1.00 | HTT (0.34) | HTTMGAMGAASIMGAM2 | |
| SCHEMBL5512174 | 0.79 | CPB1 (0.37) | HTTMGAMGAASIMGAM2 | |
| SCHEMBL673568 | 0.77 | HTT (0.34) | HTTMGAMGAASIMGAM2 | |
| Acrylamide SCHEMBL28277012 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL24358337 | 0.73 | TRPA1 (0.36) | TDP1LMNAALOX15BLMPMP22 | |
| SCHEMBL20379537 | 0.73 | TRPA1 (0.36) | TDP1LMNAALOX15BLMPMP22 | |
| SCHEMBL10817871 | 0.72 | — | — | |
| SCHEMBL10817873 | 0.72 | — | — | |
| Acetone SCHEMBL293563 | 0.71 | TRPA1 (0.35) | TDP1LMNAALOX15BLMPMP22 | |
| SCHEMBL9577379 | 0.70 | MGAM (0.38) | HTTMGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2629780-A2 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | 206 ORTHO, Inc. (US) | 2013-08-28 | — | — | EP | claimed |
| US-20120101593-A1 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | BIOS2 Medical, Inc. (US) | 2012-04-26 | — | — | US | claimed |
| WO-2012054742-A2 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | BIOS2 Medical, Inc. (US) | 2012-04-26 | — | — | WO | claimed |
| EP-0932652-B2 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF SE (DE) | 2008-04-23 | — | — | EP | claimed |
| EP-0932652-B1 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF AG (DE) | 2002-12-18 | — | — | EP | claimed |
| US-6242515-B1 | ESPECIALLY SEALING POLYURETHANE FOAMS WITH A CURABLE MIXTURE OF AN ADDITION COPOLYMER CONTAINING CARBONYL GROUPS AND A DI-OR POLYCARBOXYLIC ACID HYDRAZIDE | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-05 | — | — | US | claimed |
| EP-0932652-A1 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-04 | — | — | EP | claimed |
| US-5763012-A | PROTECTIVE COATINGS AND SEALS | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-09 | — | — | US | claimed |
| WO-1998016589-A1 | USE OF POLYMER DISPERSIONS AS BINDING AGENTS FOR SEALING COMPOUNDS AND COATING COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-23 | — | — | WO | claimed |
| EP-3838934-B1 | ADHESIVE COMPOSITION FOR PAPER BONDING | TESA SE (DE) | 2025-05-14 | — | — | EP | disclosed |
| US-12054655-B2 | Pressure-sensitive adhesive for paper bonds | TESA SE (DE) | 2024-08-06 | — | — | US | disclosed |
| US-20240123115-A1 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | 206 ORTHO, INC. (US) | 2024-04-18 | — | — | US | disclosed |
| US-11850323-B2 | Implantable polymer for bone and vascular lesions | 206 ORTHO, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| US-20210189191-A1 | PRESSURE-SENSITIVE ADHESIVE FOR PAPER BONDS | TESA SE (DE) | 2021-06-24 | — | — | US | disclosed |
| EP-0046941-B1 | THERMOPLASTIC MASS WITH INCREASED COHESIVE STRENGTH AND A MINOR FLOW-TENDENCY, AND PROCESS FOR ITSPREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-12-27 | — | — | EP | disclosed |
| US-4233163-A | CURABLE POLYPHOSPHONATES | STAUFFER CHEMICAL COMPANY (US) | 1980-11-11 | — | — | US | disclosed |
| US-4076650-A | COPPER SULFATE, HYDROGEN PEROXIDE CURING CATALYST FOR COPOLYCONDENSED OLIGOMERIC VINYL PHOSPHONATE | STAUFFER CHEMICAL COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
| US-4067927-A | TEXTILES | STAUFFER CHEMICAL COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4052158-A | CATALYTIC FREE RADICAL POLYMERIZATION, CURING | STAUFFER CHEMICAL COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4017257-A | Textiles fire-retardant treated with copolycondensed vinylphosphonates and process | STAUFFER CHEMICAL COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123115-A1 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | HPD, SMCHD1, IMPDH1 | HTT 1792/4885MGAM 397/4885GAA 4065/4885 |
| US-11850323-B2 | Implantable polymer for bone and vascular lesions | HPD, SMCHD1, IMPDH1 | HTT 1792/4885MGAM 397/4885GAA 4065/4885 |
| US-20120101593-A1 | IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS | BMP2, SOST, CD47 | HTT 4270/4885MGAM 108/4885GAA 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.